Supervisory Meeting at Politecnico di Torino. February 2019
First EMERALD Network-Wide Event Core Transferable Skills Week. February 2019
All 13 ESRs have been recruited!
First EMERALD General Workshop in Belgrade, Serbia. May 2019
MidTerm Network Meeting. Naples, Italy. September 2019
Politecnico di Torino's unit in "Festival della Tecnologia". November 2019
EMERALD is the coherent action of leading European engineering groups involved in electromagnetic (EM) technology for medical imaging to form a cohort of highly skilled researchers capable of accelerating the translation of this technology “from research bench to patient bedside”.
Nowadays, medical imaging technologies play a key role to face the ever-growing number of challenges due to aging populations, as they are the essential clinical tool to deliver accurate initial diagnosis and monitor the evolution of disease over time. For this reason, a whole range of new imaging modalities is currently being developed to supplement and support current modalities. Among these technologies, there is EM imaging, which involves the illumination of the portion of the body under investigation with low-power non-ionizing EM waves (in the microwave spectrum) and the use of the resultant backscattered signals to generate images of the internal structures of the body.
The scientific objective pursued by the EMERALD action is to accelerate translation of research in EM medical imaging into clinical prototypes. To this end, EMERALD will establish a group of 13 outstanding early stage researchers who will be the European leaders in this field, through a unique scientific and training programme. The EMERALD trained researchers will drive the future developments of EM imaging technology, thanks to the targeted skills, they will attain, and their established connections with clinicians and stakeholders.
The EMERALD consortium involves academic institutions, industrial partners, hospitals and university medical centers (as partner organizations). The success of EMERALD will ensure that all achieved innovative technological developments will be translated into benefits to the end user community and potentially taken to market, with an impact on both the European society and scientific community.